Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors

Journal of Pediatrics

Volumn 158, Issue 3, 2011, Pages 433-436

  Josefson, Jami ^a   Listernick, Robert ^a   Fangusaro, Jason R ^a   Charrow, Joel ^a   Habiby, Reema ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GROWTH HORMONE; LEUPRORELIN; LUTEINIZING HORMONE; NEUROFIBROMIN; SEX HORMONE; SOMATOMEDIN C; VINCRISTINE;

ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; ENDOCRINE DISEASE; EVALUATION; FEMALE; GROWTH HORMONE EXCESS; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS TUMOR; MALE; OPTIC CHIASM; OPTIC PATHWAY TUMOR; ORAL GLUCOSE TOLERANCE TEST; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; TUMOR; TUMOR GROWTH;

ACROMEGALY; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS; PUBERTY, PRECOCIOUS;

EID: 79951581468     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.09.013     Document Type: Article

References (21)

1. S.M. Orme, R.J. McNally, R.A. Cartwright, and P.E. Belchetz Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group J Clin Endocrinol Metab 83 1998 2730 2734 (Pubitemid 28493768)
2. M.J. Crawford, and J.M. Buckler Optic gliomata affecting twins with neurofibromatosis Dev Med Child Neurol 25 1983 370 373 (Pubitemid 13095894)
3. M.S. Duchowny, R. Katz, and R.L. Bejar Hypothalamic mass and gigantism in neurofibromatosis: treatment with bromocriptine Ann Neurol 15 1984 302 304 (Pubitemid 14164750)
4. T.J. Manski, C.S. Haworth, B.J. Duval-Arnould, and E.J. Rushing Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism. Case report J Neurosurg 81 1994 595 600 (Pubitemid 24303287)
5. J.S. Fuqua, and G.D. Berkovitz Growth hormone excess in a child with neurofibromatosis type 1 and optic pathway tumor: a patient report Clin Pediatr (Phila) 37 1998 749 752 (Pubitemid 29004006)
6. F.M. Drimmie, A.C. MacLennan, J.A. Nicoll, E. Simpson, E. McNeill, and M.D. Donaldson Gigantism due to growth hormone excess in a boy with optic glioma Clin Endocrinol (Oxf) 53 2000 535 538
7. K.M. Main, A. Sehested, and U. Feldt-Rasmussen Pegvisomant treatment in a 4-year-old girl with neurofibromatosis type 1 Horm Res 65 2006 1 5 (Pubitemid 43177310)
8. R. Habiby, B. Silverman, R. Listernick, and J. Charrow Precocious puberty in children with neurofibromatosis type 1 J Pediatr 126 1995 364 367
9. R. Vassilopoulou-Sellin, M.J. Klein, and J.K. Slopis Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions Pediatr Neurol 22 2000 355 358 (Pubitemid 30410786)
10. B. Hegedus, and T.H. Yeh Lee da Y, Emnett RJ, Li J, Gutmann DH. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis Hum Mol Genet 17 2008 2956 2966
11. R.V. Lloyd, L. Jin, A. Chang, E. Kulig, S.A. Camper, and B.D. Ross Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis Am J Pathol 141 1992 895 906
12. R. Listernick, J. Charrow, M.J. Greenwald, and N.B. Esterly Optic gliomas in children with neurofibromatosis type 1 J Pediatr 114 1989 788 792 (Pubitemid 19122974)
13. Neurofibromatosis Natl Inst Health Consens Dev Conf Consens Statement 6 1987 1 7
14. V.N. Brito, M.C. Batista, M.F. Borges, A.C. Latronico, M.B. Kohek, and A.C. Thirone Diagnostic value of fluorometric assays in the evaluation of precocious puberty J Clin Endocrinol Metab 84 1999 3539 3544 (Pubitemid 30648836)
15. M. Misra, J. Cord, R. Prabhakaran, K.K. Miller, and A. Klibanski Growth hormone suppression after an oral glucose load in children J Clin Endocrinol Metab 92 2007 4623 4629 (Pubitemid 350223436)
16. B. Ergun-Longmire, A.C. Mertens, P. Mitby, J. Qin, G. Heller, and W. Shi Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor J Clin Endocrinol Metab 91 2006 3494 3498 (Pubitemid 44402126)
17. A.J. Swerdlow, R.E. Reddingius, C.D. Higgins, H.A. Spoudeas, K. Phipps, and Z. Qiao Growth hormone treatment of children with brain tumors and risk of tumor recurrence J Clin Endocrinol Metab 85 2000 4444 4449 (Pubitemid 32157616)
18. T. Moshang Jr., A.C. Rundle, D.A. Graves, J. Nickas, A. Johanson, and A. Meadows Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience J Pediatr 128 1996 S4 S7
19. R. Cozzi, M. Montini, R. Attanasio, M. Albizzi, G. Lasio, and S. Lodrini Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage J Clin Endocrinol Metab 91 2006 1397 1403
20. P.J. Trainer, W.M. Drake, L. Katznelson, P.U. Freda, V. Herman-Bonert, and A.J. van der Lely Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant N Engl J Med 342 2000 1171 1177 (Pubitemid 30211048)
21. N. Goldenberg, M.S. Racine, P. Thomas, B. Degnan, W. Chandler, and A. Barkan Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant J Clin Endocrinol Metab 93 2008 2953 2956